Release Date: 17/10/11 08:25 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 20.31KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%